149 related articles for article (PubMed ID: 19452576)
1. Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer.
Salcido-Neyoy ME; Sierra-Santoyo A; Beltrán-Ramírez O; Macías-Pérez JR; Villa-Treviño S
World J Gastroenterol; 2009 May; 15(19):2345-50. PubMed ID: 19452576
[TBL] [Abstract][Full Text] [Related]
2. Cancer prevention mediated by caffeic acid phenethyl ester involves cyp2b1/2 modulation in hepatocarcinogenesis.
Beltrán-Ramírez O; Pérez RM; Sierra-Santoyo A; Villa-Treviño S
Toxicol Pathol; 2012 Apr; 40(3):466-72. PubMed ID: 22291063
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib activates Stat5 and restores or increases the expression of growth hormone-regulated genes in hepatocarcinogenesis.
Arellanes-Robledo J; Salcido-Neyoy ME; Márquez-Quiñones A; García-Román R; Beltrán-Ramírez O; Le Berre V; Sokol S; François JM; Villa-Treviño S
Anticancer Drugs; 2010 Apr; 21(4):411-22. PubMed ID: 20145537
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.
Fulzele SV; Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2006 Mar; 58(3):327-36. PubMed ID: 16536899
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of methyl and ethyl nitrosamines by cytochrome P450 2E1 and 2B1.
Chowdhury G; Calcutt MW; Nagy LD; Guengerich FP
Biochemistry; 2012 Dec; 51(50):9995-10007. PubMed ID: 23186213
[TBL] [Abstract][Full Text] [Related]
6. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats.
Galant LW; de Mattos AA; Menti E; Valiatti FB; de Mattos AZ; Porawski M; Hartmann A; Rhoden CR
Ann Hepatol; 2013; 12(3):425-33. PubMed ID: 23619259
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.
Márquez-Rosado L; Trejo-Solís MC; García-Cuéllar CM; Villa-Treviño S
J Hepatol; 2005 Oct; 43(4):653-60. PubMed ID: 16023763
[TBL] [Abstract][Full Text] [Related]
8. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
[TBL] [Abstract][Full Text] [Related]
9. Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats.
Kim DJ; Lee KK; Han BS; Ahn B; Bae JH; Jang JJ
Jpn J Cancer Res; 1994 Jun; 85(6):578-83. PubMed ID: 8063610
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the anticarcinogenic effect of caffeic acid phenethyl ester in the resistant hepatocyte model involves modifications of cytochrome P450.
Beltrán-Ramírez O; Alemán-Lazarini L; Salcido-Neyoy M; Hernández-García S; Fattel-Fazenda S; Arce-Popoca E; Arellanes-Robledo J; García-Román R; Vázquez-Vázquez P; Sierra-Santoyo A; Villa-Treviño S
Toxicol Sci; 2008 Jul; 104(1):100-6. PubMed ID: 18397917
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of diethylnitrosamine by nasal mucosa and hepatic microsomes from hamster and rat: species specificity of nasal mucosa.
Longo V; Citti L; Gervasi PG
Carcinogenesis; 1986 Aug; 7(8):1323-8. PubMed ID: 3089639
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein β and cyclooxygenase-2.
Lu XL; He SX; Ren MD; Wang YL; Zhang YX; Liu EQ
Mol Med Rep; 2012 Mar; 5(3):637-44. PubMed ID: 22159471
[TBL] [Abstract][Full Text] [Related]
13. 1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital.
Banakar MC; Paramasivan SK; Chattopadhyay MB; Datta S; Chakraborty P; Chatterjee M; Kannan K; Thygarajan E
World J Gastroenterol; 2004 May; 10(9):1268-75. PubMed ID: 15112340
[TBL] [Abstract][Full Text] [Related]
14. Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver.
Mori Y; Koide A; Kobayashi Y; Furukawa F; Hirose M; Nishikawa A
Mutagenesis; 2003 Jan; 18(1):87-93. PubMed ID: 12473741
[TBL] [Abstract][Full Text] [Related]
15. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
16. Anticarcinogenic effect and modification of cytochrome P450 2E1 by dietary garlic powder in diethylnitrosamine-initiated rat hepatocarcinogenesis.
Park KA; Kweon S; Choi H
J Biochem Mol Biol; 2002 Nov; 35(6):615-22. PubMed ID: 12470597
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of cytochrome P450 and possible correlation with preneoplastic changes in early stage of rat hepatocarcinogenesis.
Liu LL; Gong LK; Qi XM; Cai Y; Wang H; Wu XF; Xiao Y; Ren J
Acta Pharmacol Sin; 2005 Jun; 26(6):737-44. PubMed ID: 15916741
[TBL] [Abstract][Full Text] [Related]
18. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
19. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
Dewa Y; Nishimura J; Muguruma M; Jin M; Saegusa Y; Okamura T; Tasaki M; Umemura T; Mitsumori K
Toxicology; 2008 Feb; 244(2-3):179-89. PubMed ID: 18164116
[TBL] [Abstract][Full Text] [Related]
20. Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liver.
Mori Y; Koide A; Kobayashi Y; Morimura K; Kaneko M; Fukushima S
Mutagenesis; 2002 May; 17(3):251-6. PubMed ID: 11971997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
